HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/2/H590    most recent 00379.2005v2 00379.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Higuchi, Y. Articles by Feldman, A. M. Search for Related Content PubMed PubMed Citation Articles by Higuchi, Y. Articles by Feldman, A. M.

Cardioprotection afforded by NF-B ablation is associated with activation of Akt in mice overexpressing TNF-

¹Center For Translational Medicine, Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania; ²Department of Pharmacology and Cell Biophysics, University of Cincinnati, Cincinnati, Ohio; ³Cardiovascular Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and ⁴Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

Submitted 18 April 2005 ; accepted in final form 15 September 2005

When selectively overexpressed in mouse heart, TNF- effects the development of a cardiomyopathy that closely mimics that seen in human failing hearts. It has been suggested that two intracellular signaling pathways, the Akt protein kinase and the NF-B transcription factor, mediated TNF- signaling. The present experiments assessed the effects of TNF- overexpression on these two target proteins in vivo. We measured cardiac Akt kinase phosphorylation and NF-B activity in mice overexpressing TNF- (TNF1.6). Both basal and insulin-stimulated Akt phosphorylation were reduced by almost 70% by TNF- overexpression. By contrast, NF-B was robustly activated. These effects were absent when TNF- receptor 1 (TNFR1) was selectively ablated. Cardiomyocyte-specific overexpression of the dominant-negative inhibitory B protein transgene and subsequent inhibition of NF-B activity attenuated the effects of TNF- on Akt phosphorylation. NF-B inhibition also significantly improved fractional shortening and diminished ventricular hypertrophy and survival without affecting infiltrative inflammation or cytokine expression. Thus, while overexpression of TNF- effected a marked Akt inhibition and NF-B activation in mouse hearts, inhibition of NF-B offered salutary benefits mediated at least in part through activation of Akt.

tumor necrosis factor-; insulin signaling; TNF- receptor; protein kinase B; dominant-negative inhibitory B protein transgene

This article has been cited by other articles:

				S. Wu, R. Yin, R. Ernest, Y. Li, O. Zhelyabovska, J. Luo, Y. Yang, and Q. Yang Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-{kappa}B signalling Cardiovasc Res, June 27, 2009; (2009) cvp180v2. [Abstract] [Full Text] [PDF]

				P. J. H. Smeets, H. M. de Vogel-van den Bosch, P. H. M. Willemsen, A. P. Stassen, T. Ayoubi, G. J. van der Vusse, and M. van Bilsen Transcriptomic analysis of PPAR{alpha}-dependent alterations during cardiac hypertrophy Physiol Genomics, December 12, 2008; 36(1): 15 - 23. [Abstract] [Full Text] [PDF]

				P. J. H. Smeets, B. E. J. Teunissen, A. Planavila, H. de Vogel-van den Bosch, P. H. M. Willemsen, G. J. van der Vusse, and M. van Bilsen Inflammatory Pathways Are Activated during Cardiomyocyte Hypertrophy and Attenuated by Peroxisome Proliferator-activated Receptors PPAR{alpha} and PPAR{delta} J. Biol. Chem., October 24, 2008; 283(43): 29109 - 29118. [Abstract] [Full Text] [PDF]

				P. J.H. Smeets, B. E.J. Teunissen, P. H.M. Willemsen, F. A. van Nieuwenhoven, A. E. Brouns, B. J.A. Janssen, J. P.M. Cleutjens, B. Staels, G. J. van der Vusse, and M. van Bilsen Cardiac hypertrophy is enhanced in PPAR{alpha}-/- mice in response to chronic pressure overload Cardiovasc Res, April 1, 2008; 78(1): 79 - 89. [Abstract] [Full Text] [PDF]

				A. A. Elmarakby, J. E. Quigley, J. J. Olearczyk, A. Sridhar, A. K. Cook, E. W. Inscho, D. M. Pollock, and J. D. Imig Chemokine Receptor 2b Inhibition Provides Renal Protection in Angiotensin II Salt Hypertension Hypertension, December 1, 2007; 50(6): 1069 - 1076. [Abstract] [Full Text] [PDF]

				H. Funakoshi, T. O. Chan, J. C. Good, J. R. Libonati, J. Piuhola, X. Chen, S. M. MacDonnell, L. L. Lee, D. E. Herrmann, J. Zhang, et al. Regulated Overexpression of the A1-Adenosine Receptor in Mice Results in Adverse but Reversible Changes in Cardiac Morphology and Function Circulation, November 21, 2006; 114(21): 2240 - 2250. [Abstract] [Full Text] [PDF]

				D. Hilfiker-Kleiner, U. Landmesser, and H. Drexler Molecular Mechanisms in Heart Failure: Focus on Cardiac Hypertrophy, Inflammation, Angiogenesis, and Apoptosis J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A56 - A66. [Abstract] [Full Text] [PDF]